Halt Of Merck’s HIV Vaccine Trial Should Not ‘Slow Progress’ Toward Future Vaccine Development, Opinion Piece Says
Although many people “felt robbed” by the announcement last week that Merck’s trial of an experimental HIV vaccine had been halted, it would be “worse [to] allow the news to slow progress” toward development of future HIV vaccines, Seth Berkley, president and CEO of the International AIDS Vaccine Initiative, writes in a
